| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2fb71a5ffde9b1324015ded092f1042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12861d5900d039e53c217c42fa372d26 |
| publicationDate |
2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006083711-A1 |
| titleOfInvention |
Tachykinin receptor antagonists |
| abstract |
The present invention provides novel compounds of Formula (I) compositions thereof, and methods for using the compounds in the treatment of disorders associated with an excess of tachykinins. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017031215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010513546-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9708291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287287-B2 |
| priorityDate |
2005-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |